Oncology Institute Stock In The News
| TOI Stock | USD 0.17 0.02 13.33% |
Our overall analysis of Oncology Institute's news coverage and content from conventional and social sources shows investors' bearish mood towards Oncology Institute. The specific impact of Oncology Institute news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Oncology Institute's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Oncology Institute headlines in addition to utilizing other, more conventional financial analysis modules. Check out Oncology Institute Backtesting and Oncology Institute Hype Analysis. For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.
Oncology |
Oncology Institute Today Top News and Investor Outlook
Oncology Institute Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Oncology and other traded companies coverage with news coverage. We help investors stay connected with Oncology headlines for the 26th of November to make an informed investment decision based on correlating the impacts of news items on Oncology Stock performance. Please note that trading solely based on the Oncology Institute hype is not for everyone as timely availability and quick action are needed to avoid losses.
Oncology Institute stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Oncology earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Oncology Institute that are available to investors today. That information is available publicly through Oncology media outlets and privately through word of mouth or via Oncology internal channels. However, regardless of the origin, that massive amount of Oncology data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Oncology Institute news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Oncology Institute relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Oncology Institute's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Oncology Institute alpha.
Oncology Largest EPS Surprises
Earnings surprises can significantly impact Oncology Institute's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-08-08 | 2023-06-30 | -0.17 | -0.19 | -0.02 | 11 | ||
2022-08-09 | 2022-06-30 | -0.11 | -0.09 | 0.02 | 18 | ||
2023-11-08 | 2023-09-30 | -0.13 | -0.19 | -0.06 | 46 | ||
2024-08-13 | 2024-06-30 | -0.1 | -0.17 | -0.07 | 70 | ||
2023-03-09 | 2022-12-31 | -0.18 | -0.25 | -0.07 | 38 | ||
2022-11-09 | 2022-09-30 | -0.18 | -0.25 | -0.07 | 38 |
Oncology Institute Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Oncology Institute Stock. Current markets are strongly bearish. About 75% of major world exchanges and indexes are down. See today's market update for more information.
22nd of November 2024
Acquisition by Hively Brad of 44000 shares of Oncology Institute subject to Rule 16b-3 at MacroaxisInsider
15th of November 2024
The Oncology Institute, Inc. Q3 2024 Earnings Call Transcript at insidermonkey.com
12th of November 2024
Disposition of 117142 shares by Virnich Daniel of Oncology Institute subject to Rule 16b-3 at MacroaxisInsider
7th of November 2024
SHAREHOLDER ALERT Levi Korsinsky, LLP Notifies Investors of an Investigation into The Onco... at accesswire.com
5th of November 2024
SHAREHOLDER ALERT Levi Korsinsky, LLP Notifies Investors of an Investigation into The Onco... at accesswire.com
31st of October 2024
SHAREHOLDER ALERT Levi Korsinsky, LLP Informs Shareholders of an Investigation into The On... at accesswire.com
28th of October 2024
SHAREHOLDER ALERT Levi Korsinsky, LLP Informs Shareholders of an Investigation into The On... at accesswire.com
23rd of October 2024
SHAREHOLDER ALERT Levi Korsinsky, LLP Informs Shareholders of an Investigation into The On... at accesswire.com
15th of October 2024
SHAREHOLDER ALERT Levi Korsinsky, LLP Notifies Shareholders of an Investigation into The O... at accesswire.com
10th of October 2024
SHAREHOLDER ALERT Levi Korsinsky, LLP Informs Shareholders of an Investigation into The On... at accesswire.com
23rd of September 2024
The Oncology Institute Announces CFO Transition at finance.yahoo.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Oncology Institute in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Oncology Institute's short interest history, or implied volatility extrapolated from Oncology Institute options trading.
Check out Oncology Institute Backtesting and Oncology Institute Hype Analysis. For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oncology Institute. If investors know Oncology will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oncology Institute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.77) | Revenue Per Share 4.873 | Quarterly Revenue Growth 0.229 | Return On Assets (0.19) | Return On Equity (1.26) |
The market value of Oncology Institute is measured differently than its book value, which is the value of Oncology that is recorded on the company's balance sheet. Investors also form their own opinion of Oncology Institute's value that differs from its market value or its book value, called intrinsic value, which is Oncology Institute's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oncology Institute's market value can be influenced by many factors that don't directly affect Oncology Institute's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oncology Institute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncology Institute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncology Institute's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.